SCHEMBL3836513

SCHEMBL3836513

CC(C)(C)OC(=O)N(C1CNC1)S(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CCR5 P51681 4/20 0.41
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ F2 P00734 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ STAT5B P51692 1/20 0.35
▸ ESR2 Q92731 3/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3837214 0.87 HTR2A (0.38) KMT2AMEN1ALDH1A1HTR2AHTR2C
SCHEMBL3839948 0.80 KMT2A (0.41) KMT2AMEN1ALDH1A1KDM4EHSD11B1
SCHEMBL1511696 0.76 F2 (0.37) CCR5KMT2AALDH1A1F2HSD11B1
SCHEMBL15219222 0.74 CCR5 (0.40) CCR5KMT2AMEN1ALDH1A1KDM4E
SCHEMBL28034923 0.74 HSD11B1 (0.56) CCR5KMT2AALDH1A1KDM4EF2
SCHEMBL6980390 0.72 CTSD (0.53) HSD11B1
SCHEMBL26413544 0.72 HSD11B1 (0.45) CCR5KMT2AALDH1A1F2HSD11B1
SCHEMBL925152 0.71 NPSR1 (0.47) CCR5KMT2AMEN1HSD11B1
SCHEMBL857496 0.71 HSD17B10 (0.42) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL26413513 0.71 HSD11B1 (0.44) CCR5KMT2AALDH1A1F2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111402-A2 AMINOPYRAZOLE KINASE INHIBITORS Brystol-Myers Squibb Company (US) 2009-10-28 — — EP disclosed
WO-2008086128-A2 AMINOPYRAZOLE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-07-17 — — WO disclosed
Send feedback